Cross Country Healthcare Statistics
Total Valuation
CCRN has a market cap or net worth of $379.33 million. The enterprise value is $314.47 million.
| Market Cap | 379.33M |
| Enterprise Value | 314.47M |
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CCRN has 33.81 million shares outstanding. The number of shares has decreased by -5.80% in one year.
| Shares Outstanding | 33.81M |
| Shares Change (YoY) | -5.80% |
| Shares Change (QoQ) | -1.84% |
| Owned by Insiders (%) | 6.17% |
| Owned by Institutions (%) | 103.65% |
| Float | 31.70M |
Valuation Ratios
The trailing PE ratio is 45.45 and the forward PE ratio is 22.62. CCRN's PEG ratio is 2.26.
| PE Ratio | 45.45 |
| Forward PE | 22.62 |
| PS Ratio | 0.25 |
| Forward PS | 0.26 |
| PB Ratio | 0.85 |
| P/FCF Ratio | 2.38 |
| PEG Ratio | 2.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.54, with an EV/FCF ratio of 1.97.
| EV / Earnings | 37.03 |
| EV / Sales | 0.20 |
| EV / EBITDA | 6.54 |
| EV / EBIT | 10.41 |
| EV / FCF | 1.97 |
Financial Position
The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.07 |
| Quick Ratio | 2.99 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.03 |
| Interest Coverage | 13.22 |
Financial Efficiency
Return on equity (ROE) is 1.87% and return on invested capital (ROIC) is 3.97%.
| Return on Equity (ROE) | 1.87% |
| Return on Assets (ROA) | 2.75% |
| Return on Capital (ROIC) | 3.97% |
| Revenue Per Employee | $119,966 |
| Profits Per Employee | $647 |
| Employee Count | 13,131 |
| Asset Turnover | 2.29 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CCRN has paid $8.10 million in taxes.
| Income Tax | 8.10M |
| Effective Tax Rate | 48.83% |
Stock Price Statistics
The stock price has decreased by -42.08% in the last 52 weeks. The beta is 0.65, so CCRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -42.08% |
| 50-Day Moving Average | 13.21 |
| 200-Day Moving Average | 15.86 |
| Relative Strength Index (RSI) | 31.84 |
| Average Volume (20 Days) | 693,337 |
Short Selling Information
The latest short interest is 3.11 million, so 9.18% of the outstanding shares have been sold short.
| Short Interest | 3.11M |
| Short Previous Month | 4.00M |
| Short % of Shares Out | 9.18% |
| Short % of Float | 9.79% |
| Short Ratio (days to cover) | 2.75 |
Income Statement
In the last 12 months, CCRN had revenue of $1.58 billion and earned $8.49 million in profits. Earnings per share was $0.25.
| Revenue | 1.58B |
| Gross Profit | 335.95M |
| Operating Income | 30.21M |
| Pretax Income | 16.60M |
| Net Income | 8.49M |
| EBITDA | 48.08M |
| EBIT | 30.21M |
| Earnings Per Share (EPS) | $0.25 |
Balance Sheet
The company has $69.60 million in cash and $4.74 million in debt, giving a net cash position of $64.86 million or $1.92 per share.
| Cash & Cash Equivalents | 69.60M |
| Total Debt | 4.74M |
| Net Cash | 64.86M |
| Net Cash Per Share | $1.92 |
| Equity (Book Value) | 439.06M |
| Book Value Per Share | 13.15 |
| Working Capital | 227.64M |
Cash Flow
In the last 12 months, operating cash flow was $170.80 million and capital expenditures -$11.36 million, giving a free cash flow of $159.44 million.
| Operating Cash Flow | 170.80M |
| Capital Expenditures | -11.36M |
| Free Cash Flow | 159.44M |
| FCF Per Share | $4.72 |
Margins
Gross margin is 21.33%, with operating and profit margins of 1.92% and 0.54%.
| Gross Margin | 21.33% |
| Operating Margin | 1.92% |
| Pretax Margin | 1.05% |
| Profit Margin | 0.54% |
| EBITDA Margin | 3.05% |
| EBIT Margin | 1.92% |
| FCF Margin | 10.12% |
Dividends & Yields
CCRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.80% |
| Shareholder Yield | 5.80% |
| Earnings Yield | 2.24% |
| FCF Yield | 42.03% |
Analyst Forecast
The average price target for CCRN is $18.75, which is 67.11% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.75 |
| Price Target Difference | 67.11% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CCRN has an Altman Z-Score of 6.43 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.43 |
| Piotroski F-Score | 5 |